Cubist Systematic Strategies’s OptiNose OPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-972
Closed -$28.2K 4080
2023
Q1
$28.2K Buy
+972
New +$25.9K ﹤0.01% 3638
2021
Q3
Sell
-1,130
Closed -$53K 3125
2021
Q2
$53K Sell
1,130
-872
-44% -$44.5K ﹤0.01% 2782
2021
Q1
$111K Sell
2,002
-991
-33% -$60.3K ﹤0.01% 2623
2020
Q4
$186K Buy
+2,993
New +$183K ﹤0.01% 2264
2019
Q3
Sell
-770
Closed -$82K 2394
2019
Q2
$82K Buy
+770
New +$101K ﹤0.01% 2269
2019
Q1
Sell
-2,810
Closed -$261K 2373
2018
Q4
$261K Buy
+2,810
New +$401K 0.01% 1374

Other funds holding OPTN

Cubist Systematic Strategies's OPTN Position: Q2 2023 in Review

Cubist Systematic Strategies sold out of OptiNose (OPTN) in Q2 2023, closing a stake of 972 shares — an estimated $28.2K sold.

Cubist Systematic Strategies first reported a position in OPTN in Q4 2018 and held it in 6 quarters. The position peaked at $261K in Q4 2018. 61 funds tracked by Wall St. Rank hold OPTN as of Q2 2023.

  • Cubist Systematic Strategies reported no remaining OptiNose position as of Q2 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 972 OptiNose shares in Q2 2023, an estimated $28.2K.
  • Cubist Systematic Strategies first reported a position in OptiNose in Q4 2018 and held it in 6 quarters.
  • Cubist Systematic Strategies's OptiNose position peaked at $261K in Q4 2018.
  • 61 funds tracked by Wall St. Rank held OptiNose as of Q2 2023.

Based on Cubist Systematic Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.